Neogen(NEOG)
Search documents
Neogen Suffers From Competitive Pressure, Macroeconomic Woes
ZACKS· 2024-08-28 17:56
Neogen's (NEOG) vast international trade is impacted by global macroeconomic issues. Also, a tough competitive landscape weighs on the stock. NEOG stock carries a Zacks Rank #4 (Sell). Neogen's international business continues to be affected by currency movements. The current macroeconomic environment has adversely impacted Neogen's financial operations. Governments and insurance companies continue to look for ways to contain the rising cost of healthcare. This might put pressure on players in the healthcar ...
Neogen Announced as an Official Sponsor of US Equestrian
Prnewswire· 2024-08-22 12:45
LEXINGTON, Ky., Aug. 22, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has formed a relationship with US Equestrian to help provide better equine care solutions for veterinarians and horse owners. Neogen and US Equestrian will together develop member-accessible educational materials on best practices, prevention techniques, and recommended treatment protocols for cases of equine botulism, a progressive neuromuscular disease that leads to weakness and muscle paralysis in equ ...
Is the Options Market Predicting a Spike in Neogen (NEOG) Stock?
ZACKS· 2024-08-02 13:35
Investors in Neogen Corporation (NEOG) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $17.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could a ...
Neogen (NEOG) Q4 Earnings Miss Estimates, Margins Crash
ZACKS· 2024-07-31 13:10
Neogen Corporation (NEOG) reported fourth-quarter fiscal 2024 earnings per share (EPS) of 10 cents, down 28.6% from the prior year's comparable period figure. The reported figure also missed the Zacks Consensus Estimate by 16.7%. Revenues in the fiscal fourth quarter fell 2.1% on a year-over-year basis to $236.8 million. Core revenues were 2%. Acquisitions and discontinued product lines contributed 0.1%, while foreign currency had a negative impact of 4.2%. However, the metric surpassed the Zacks Consensus ...
Neogen(NEOG) - 2024 Q4 - Annual Report
2024-07-30 17:58
FORM 10-K MICHIGAN 38-2367843 (State of other jurisdiction of incorporation organization) (I.R.S. Employer Identification No.) 620 Lesher Place Lansing, Michigan 48912 (Address of principal executive offices, including zip code) 517-372-9200 (Registrant's telephone number, including area code) (Title of Class) Certain portions of the registrant's definitive proxy statement to be prepared pursuant to Regulation 14a and filed in connection with solicitation of proxies for its October 24, 2024 annual meeting o ...
Neogen(NEOG) - 2024 Q4 - Earnings Call Transcript
2024-07-30 16:33
Neogen Corporation (NASDAQ:NEOG) Q4 2024 Results Conference Call July 30, 2024 8:00 AM ET Company Participants Bill Waelke - IR John Adent - CEO Dave Naemura - CFO Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation Fourth Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, July 30, 2024. I would now like to turn the conference over to Bill Wael ...
Neogen (NEOG) Lags Q4 Earnings Estimates
ZACKS· 2024-07-30 13:30
Neogen (NEOG) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for nonrecurring items. Neogen, which belongs to the Zacks Medical - Products industry, posted revenues of $236.79 million for the quarter ended May 2024, surpassing the Zacks Consensus Estimate by 5.14%. This compares to year-ago revenues of $241.81 million. The company has topped consensus revenue est ...
Neogen Announces Fourth-Quarter 2024 Results
Prnewswire· 2024-07-30 11:00
Revenue of $236.8 million. Net loss of $5.4 million; $(0.02) per diluted share. Adjusted Net Income of $22.4 million; $0.10 per diluted share. Adjusted EBITDA of $53.0 million. "After crossing multiple significant integration milestones in the third quarter related to the integration of the former 3M Food Safety business, progress continued on multiple fronts in the fourth quarter," said John Adent, Neogen's President and Chief Executive Officer. "We completed the relocation of the sample handling product l ...
Neogen(NEOG) - 2024 Q4 - Annual Results
2024-07-30 10:59
Conference Call and Webcast Neogen Corporation will host a conference call today at 8:00 a.m. Eastern Time to discuss the Company's financial results. The live webcast of the conference call and accompanying presentation materials can be accessed through Neogen's website at neogen.com/investor-relations. For those unable to access the webcast, the conference call can be accessed by dialing (800) 836-8184 (U.S.) or +1 (646) 357-8785 (International) and requesting the Neogen Corporation Fourth Quarter 2024 Ea ...
Neogen Announces Fourth-Quarter Earnings Release Date
Prnewswire· 2024-07-11 20:30
LANSING, Mich., July 11, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Tuesday, July 30, 2024. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The live webcast can be accessed through Neogen's Investor Relations webpage, neogen.com/investor-relations, under the "Events & Presentations" subheading. Neogen Cor ...